Table 2.
Highly ranked targets with available approved drugs as chemical leads
Gene ID | Gene annotation | Drugs |
---|---|---|
016011100 | Fatty acid synthase | Cerulenina, orlistatb |
022000400 | Na+,K+ ATPase α subunit 1 | Digitoxinc, almitrined, bepridile, bretyliumf, diazoxideg, ethacrynic acidh, hydroflumethiazideh, others* |
186000500 | Serine/threonine protein kinase mTOR | Everolimusi, pimecrolimusj, sirolimusi, temsirolimusk, topotecank |
016005900 | DNA topoisomerase 1* | Irinotecank, lucanthonel, sodium stibogluconatem |
217000500 | Receptor type tyrosine phosphatase | Alendronaten, etidronic acidn |
010006100 | Calmodulin | Aprindinef, bepridile, dibucaineo, felodipinep, fluphenazineq, loperamider, phenoxybenzamines, others* |
069002800 | Ribonucleoside diphosphate reductase subunit | Cladribinek, gallium nitraten |
117003600 | Adenosine deaminase | Dipyridamolet, nelarabinek, theophyllineu, Vidarabinev |
023008600 | Dual-specificity mitogen-activated protein | Bosutinibk, trametinibk |
029000100 | LDL receptor and EGF-domain-containing protein | Gentamicinw |
170000300 | Integrin α pat 2 | Antithymocyte globulinx |
123000500 | Tyrosine protein kinase Src42A | Dasatinibk |
013002700 | NADPH cytochrome P450 reductase | Benzphetaminey, daunorubicink, ethylmorphinez, nitrofurantoinw, others* |
061001100 | DNA polymerase ɛ catalytic subunit A | Cladribinek |
025003000 | Tubulin γ1 chain | Vinblastinek |
092002800 | DNA ligase 1 | Bleomycinaa |
022003300 | Amidophosphoribosyltransferase | Fluorouracilk |
229000900 | V type proton ATPase subunit A | Alendronaten, others* |
012007400 | V type proton ATPase subunit B | Gallium nitraten |
031000300 | ADP, ATP carrier protein | Clodronaten |
304000500 | Phenylalanine 4 hydroxylase | Droxidopabb |
001008300 | Proteasome subunit β type 2 | Bortezomibk, carfilzomibk |
076002300 | Proteasome subunit β type 5 | Bortezomibk, carfilzomibk |
064003100 | DNA polymerase α catalytic subunit | Cladribinek, others* |
225000200 | Short/branched chain–specific acyl CoA | Valproic acidcc |
106001600 | Histone deacetylase | Aminophyllinedd, lovastatinee, vorinostatk, others* |
050001800 | Cytochrome c | Minocyclinew |
060007700 | Proteasome subunit β type 1 | Bortezomibk, carfilzomibk |
016000600 | NADH dehydrogenase ubiquinone Fe S protein | Doxorubicink |
Listings of approved drugs obtained from DrugBank51. Drug targets have been filtered for predicted essentiality in C. elegans, a ChEMBL Ensembl score of ≥0.5, transcript expression of >100 edgeR-normalized RNA-seq reads per kilobase of gene length in adult parasites and inferred availability of an approved and possibly suitable drug (excluding, for example, hydroxocobalamin (vitamin B12); Supplementary Tables 13 and 14). Drug purposes are indicated by footnote. Asterisks indicate other drugs (with similar activities to those listed), which are not shown.
aAntifungal.
bAnti-obesity.
cCardiac glycoside (heart failure and arrhythmia).
dRespiratory stimulant.
eAngina.
fAntiarrhythmia.
gVasodilator (hypertension).
hDiuretic (hypertension and edema).
iImmunosuppressant.
jEczema.
kCancer.
lSchistosomicide.
mLeishmaniasis.
nOsteoporosis.
oLocal anesthetic.
pCalcium channel blockers (hypertension, angina, migraine).
qAntipsychotic (schizophrenia).
rDiarrhea.
sα-adrenergic antagonist.
tVasodilator (stroke, heart attack).
uAsthma.
vAntiviral.
wAntibiotic.
xOrgan transplant.
yAnorectic.
zAnalgesic.
aaPlantar wart (veruca).
bbNeurotransmitter prodrug (hypotension).
ccAnticonvulsant and mood stabilizer.
ddBronchodilator.
eeStatin (hypercholesterolemia).